Zurex Pharma Overview
- Year Founded
-
2008
- Status
-
Out of Business
- Employees
-
11
- Latest Deal Type
-
Out of Business
Zurex Pharma General Information
Description
Developer of an antimicrobial technology designed to reduce the risks associated with infections. The company engages in the development and commercialization of anti-microbial products to overcome the scientific and technical barriers to improved skin antisepsis, reduce prep time and the risk of forming catheter-related bloodstream infections (CRBSI), enabling doctors and medical professionals to keep patients safe from infections.
Contact Information
Website
www.zurexpharma.comCorporate Office
- 2113 Eagle Drive
- Middleton, WI 53562
- United States
Corporate Office
- 2113 Eagle Drive
- Middleton, WI 53562
- United States
Zurex Pharma Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 9. Out of Business | 06-Aug-2025 | Completed | Out of Business | |||
| 8. Later Stage VC | 28-Dec-2023 | Completed | Generating Revenue | |||
| 7. Later Stage VC (Series E) | 15-Jun-2020 | Completed | Generating Revenue | |||
| 6. Later Stage VC (Series D) | 12-Jun-2018 | Completed | Generating Revenue | |||
| 5. Later Stage VC (Series C) | 11-Aug-2016 | Completed | Generating Revenue | |||
| 4. Later Stage VC (Series B) | 30-Jun-2014 | Completed | Generating Revenue | |||
| 3. Early Stage VC (Series A) | 22-May-2012 | Completed | Startup | |||
| 2. Early Stage VC | 02-Mar-2012 | $1M | $2.67M | Completed | Startup | |
| 1. Early Stage VC (Series A) | 04-May-2011 | $1.67M | $1.67M | Completed | Startup |
Zurex Pharma Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate ($) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series E | ||||||||
| Series D | ||||||||
| Series C | ||||||||
| Series B | 5,464,640 | $0.000100 | $0.07 | $0.94 | $0.94 | 1x | $0.94 | 12.08% |
| Series A | 7,413,466 | $0.000100 | $0.07 | $0.36 | $0.36 | 1x | $0.36 | 16.38% |
Zurex Pharma Comparisons
Industry
Financing
Details
Zurex Pharma Competitors (1)
One of Zurex Pharma’s competitors is Angelini Pharma, a Private Equity-Backed company based in Rome, Italy.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Angelini Pharma | Private Equity-Backed | Rome, Italy |
Zurex Pharma Patents
Zurex Pharma Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| AU-2018275134-A1 | Low-alcohol and sterilizable antimicrobial compositions and use thereof | Active | 02-Jun-2017 | ||
| AU-2018275134-B2 | Low-alcohol and sterilizable antimicrobial compositions and use thereof | Inactive | 02-Jun-2017 | ||
| CA-3065323-A1 | Low-alcohol and sterilizable antimicrobial compositions and use thereof | Pending | 02-Jun-2017 | ||
| EP-3629734-A1 | Low-alcohol and sterilizable antimicrobial compositions and use thereof | Inactive | 02-Jun-2017 | ||
| WO-2018223080-A1 | Low-alcohol and sterilizable antimicrobial compositions and use thereof | Inactive | 02-Jun-2017 | A01N31/02 |
Zurex Pharma Signals
Zurex Pharma FAQs
-
When was Zurex Pharma founded?
Zurex Pharma was founded in 2008.
-
Where is Zurex Pharma headquartered?
Zurex Pharma is headquartered in Middleton, WI.
-
What is the size of Zurex Pharma?
Zurex Pharma has 11 total employees.
-
What industry is Zurex Pharma in?
Zurex Pharma’s primary industry is Other Devices and Supplies.
-
Is Zurex Pharma a private or public company?
Zurex Pharma is a Private company.
-
What is Zurex Pharma’s current revenue?
The current revenue for Zurex Pharma is .
-
How much funding has Zurex Pharma raised over time?
Zurex Pharma has raised $40.5M.
-
Who are Zurex Pharma’s competitors?
Angelini Pharma is a competitor of Zurex Pharma.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process